The goal of the West Virginia Clinical and Translation Science Institute's (WVCTSI) IDeA-CTR application is to expand our infrastructure for, and practice of, clinical and translational research to a level competitive for a Clinical and Translational Science Award (CTSA). To this end, the WVCTSI was established in 2008 as the organizational home supporting research to address the health and healthcare needs of the people of West Virginia and Central Appalachia, and ultimately to eliminate health disparities. To realize our ambitious goal, the WVCTSI, which includes West Virginia University, Charleston Area Medical Center, West Virginia School of Osteopathic Medicine, and West Virginia United Health Systems, has partnered with the Appalachian Translational Research Institute, which was founded by our IDeA state partner and CTSA recipient the University of Kentucky. The WVCTSI will achieve its goal through pursuit of three aims: 1) Grow the WVCTSI as an academic home and a catalyst for clinical and translational research that targets cancer, cardiovascular-stroke, and obesity related diseases;2) Establish cross cutting research partnerships among the WVCTSI partnered institutions and collaborating CTSAs at University of Kentucky, Ohio State University, and Indiana University to increase our research capacity;and 3) Utilize innovative recruitment, training, and mentoring strategies to develop clinical and translational scientists at each of the WVCTSI institutions.
These aims are addressed through recruitment and support of clinical and translational scientists and a broad educational and mentoring program. In addition, participating faculty are provided with research resources that include biostatistics, clinical informatics, and access to a range of pilot funding mechanisms. Furthermore, mechanisms to streamline regulatory processes without compromising human subject protections and to engage communities fully in the research agenda are being developed. Finally, to ensure accountability and quality improvement, a robust evaluation program has been established. Overall, the WVCTSI has developed a strong infrastructure to increase the number of extramural funded clinical and translational researchers and has a well-considered plan for enhancing capacity and productivity over the next five years, positioning us for competitiveness for a CTSA.

Public Health Relevance

West Virginia suffers from numerous health disparities, notably for cancer, cardiovascular-stroke, and obesity related diseases. The WVCTSI, which includes health sciences and clinical institutions in the state and throughout central Appalachia, provides a means for the IDeA-CTR to enhance clinical and translational research and supporting infrastructure. This will result in long-term improvements to health healthcare through translation of research findings to clinical care and public health policy.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-3 (01))
Program Officer
Gorospe, Rafael
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
West Virginia University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Asano, Shinichi; O'Connell, Grant C; Lemaster, Kent C et al. (2017) Circulating leucocytes perpetuate stroke-induced aortic dysfunction. Exp Physiol 102:1321-1331
Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona et al. (2017) Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection. Adv Exp Med Biol 964:133-152
Wu, Xiaoliang; Ma, Wenjuan; Zhou, Qianghua et al. (2017) AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases. J Cancer Res Clin Oncol 143:1947-1957
Jack, Susan M; Ford-Gilboe, Marilyn; Davidov, Danielle et al. (2017) Identification and assessment of intimate partner violence in nurse home visitation. J Clin Nurs 26:2215-2228
Albrecht, Jennifer S; Slejko, Julia F; Stein, Deborah M et al. (2017) Treatment Charges for Traumatic Brain Injury Among Older Adults at a Trauma Center. J Head Trauma Rehabil 32:E45-E53
Alenzi, Ebtihag O; Kelley, George A (2017) The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: A systematic review with meta-analysis. J Diabetes Complications 31:267-272
King, Dana E; Xiang, Jun (2017) Retirement and Healthy Lifestyle: A National Health and Nutrition Examination Survey (NHANES) Data Report. J Am Board Fam Med 30:213-219
Lucke-Wold, Brandon P; Logsdon, Aric F; Turner, Ryan C et al. (2017) Endoplasmic Reticulum Stress Modulation as a Target for Ameliorating Effects of Blast Induced Traumatic Brain Injury. J Neurotrauma 34:S62-S70
Rehman, Azeem A; Turner, Ryan C; Lucke-Wold, Brandon P et al. (2017) Successful Treatment of Symptomatic Intracranial Carotid Artery Stenosis Using a 24-mm Long Bare Metal Coronary Stent. World Neurosurg 102:693.e15-693.e19
Albrecht, Jennifer S; Mullins, Daniel C; Smith, Gordon S et al. (2017) Psychotropic Medication Use among Medicare Beneficiaries Following Traumatic Brain Injury. Am J Geriatr Psychiatry 25:415-424

Showing the most recent 10 out of 739 publications